Femoston Conti 0.5 mg/2.5 mg


Tablets
scheduling status
S4
registration number
47/21.8.2/0947
What Femoston Conti 0.5 mg/2.5 mg contains
Estradiol and dydrogesterone.
other ingredients
Composition of the tablet core Lactose monohydrate Hypromellose Maize starch Colloidal (anhydrate) silica Magnesium stearate Composition of the film coating Macrogol 3350, Polyvinyl alcohol, Talc, Titanium dioxide (E171), Yellow iron oxide (E172).
Therapeutic classification
Pharmacotherapeutic category: urogenital system and sex hormones, progestogens and oestrogens, fixed combinations. ATC code: G03FA14.
© 2026 SAHPRA. ALL RIGHTS RESERVED